MedTrace Logo

Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia

NCT03149250 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-08-22

No results posted yet for this study

Summary

The study aims to investigate the impact of preeclampsia on hemostasis.

Conditions

  • Coagulation Disorder, Blood
  • Platelet Function

Interventions

DIAGNOSTIC_TEST

Aggregometry, Monitoring of plasmatic hemostasis

Multiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Principal Investigators

  • Christian F Weber, MD, PhD · Goethe University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2017-12-31
Completion
2018-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03149250 on ClinicalTrials.gov